Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors’ reply

S. Ben-Horin, B. Ungar, X. Roblin

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)760-762
Number of pages3
JournalAlimentary Pharmacology and Therapeutics
Issue number5
StatePublished - 1 Mar 2017

Cite this